Furness comes to CHPA from the Food and Drug Administration where he spent more than 25 years in various leadership roles.

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical ...

GOP fiscal hawks let their party’s tax and spending package advance toward a floor vote. But they’re threatening to tank ...

The following year, legislators in the Golden State approved another measure that, starting in 2028, will ban six food dyes — Blue 1, Blue 2, Green 3, Red 40, Yellow 5 and Yellow 6 — from being sold ...

In the US, for example, the FDA now provides the opportunity for ... A strategic partner Regulatory affairs as a function has undergone a significant shift in its strategic role and impact over ...

House Republican leaders are trying to resolve sharp differences over the giant budget reconciliation bill after it stalled ...

House Republican leaders are trying to resolve sharp differences over the giant budget reconciliation bill after it stalled ...

Two senior officials at the FDA's drug promotion regulatory office have resigned, leading to speculation that a clampdown on some direct-to-consumer (DTC) advertising of medicines could be on the way.

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug imports.

Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval "In the first quarter of 2025, we achieved a major milestone for Aquestive with the submission ...

One draft would order the NRC, the Office of Information and Regulatory Affairs (OIRA), DOE and “other agencies” to complete a “wholesale regulatory revision” of NRC rules in 18 months ...